Patient Care

Dr. Randal Dull Joins BioFuse Medical Technologies, Inc. Scientific Advisory Board

MELBOURNE, FL / ACCESSWIRE / July 11, 2023 / BioFuse Medical Technologies, Inc, a pioneering medical device company, is delighted…

12 months ago

Vizzia Technologies Expands New Healthcare RTLS Partnerships & Solutions

Innovative Tech Utilizes AI/ML, IoT/BLE Devices, and Digital WhiteboardsATLANTA, GA / ACCESSWIRE / July 11, 2023 / Vizzia Technologies, a…

12 months ago

Vizzia Technologies Expands New Healthcare RTLS Partnerships & Solutions

Innovative Tech Utilizes AI/ML, IoT/BLE Devices, and Digital WhiteboardsATLANTA, GA / ACCESSWIRE / July 11, 2023 / Vizzia Technologies, a…

12 months ago

AMD Global Telemedicine and Collain Healthcare Announce Strategic Partnership to Revolutionize Healthcare Delivery in Senior Living Facilities

CHELMSFORD, MA / ACCESSWIRE / July 11, 2023 / AMD Global Telemedicine Inc. (AMD), a renowned global leader in telemedicine…

12 months ago

AMD Global Telemedicine and Collain Healthcare Announce Strategic Partnership to Revolutionize Healthcare Delivery in Senior Living Facilities

CHELMSFORD, MA / ACCESSWIRE / July 11, 2023 / AMD Global Telemedicine Inc. (AMD), a renowned global leader in telemedicine…

12 months ago

ADHD Online Adds Social Media Addiction Assessment to Its Online Diagnostic Platform

As Surgeon General advisory reports teens' use skyrocketing and hurting their development, leader in online mental health diagnosis broadens its…

12 months ago

ADHD Online Adds Social Media Addiction Assessment to Its Online Diagnostic Platform

As Surgeon General advisory reports teens' use skyrocketing and hurting their development, leader in online mental health diagnosis broadens its…

12 months ago

MIMEDX Announces Favorable Ruling in Putative Securities Class Action Case

MARIETTA, Ga., July 11, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that…

12 months ago

Cingulate Announces Positive Top-Line Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD

Results Indicative that CTx-1301 Provides Entire Active-Day Efficacy with Optimal Onset and DurationKANSAS CITY, Kan., July 11, 2023 (GLOBE NEWSWIRE)…

12 months ago

Velocity and Privia Health Enter Partnership to Embed Clinical Research Into Practice Sites

Dr. Paul Evans, Chief Executive and President of Velocity Dr. Paul Evans, Chief Executive and President of VelocityPartnership builds on…

12 months ago